Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology
Clear cell renal cell carcinoma (ccRCC) is one frequent form of urologic malignancy with numerous genetic and epigenetic alterations. This review summarizes the recent major findings of epigenetic alterations including DNA methylation, histone modifications, microRNAs and recently identified long no...
Saved in:
Published in: | Chinese journal of cancer research Vol. 28; no. 1; pp. 80 - 91 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
China
Department of Urology, Peking University Third Hospital, Beijing 100191, China%Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China
01-02-2016
Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China AME Publishing Company |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Clear cell renal cell carcinoma (ccRCC) is one frequent form of urologic malignancy with numerous genetic and epigenetic alterations. This review summarizes the recent major findings of epigenetic alterations including DNA methylation, histone modifications, microRNAs and recently identified long noncoding RNAs in the development and progression of ccRCC. These epigenetic profilings can provide a promising means of prognostication and early diagnosis for patients with ccRCCs. With the developed high- throughput technologies nowadays, the epigenetic analyses will have possible clinical applications in the molecular pathology of ccRCC. |
---|---|
Bibliography: | 11-2591/R DNA methylation; histone modification; microRNA; long noncoding RNA; clear cell renal cell carcinoma (ccRCC) Clear cell renal cell carcinoma (ccRCC) is one frequent form of urologic malignancy with numerous genetic and epigenetic alterations. This review summarizes the recent major findings of epigenetic alterations including DNA methylation, histone modifications, microRNAs and recently identified long noncoding RNAs in the development and progression of ccRCC. These epigenetic profilings can provide a promising means of prognostication and early diagnosis for patients with ccRCCs. With the developed high- throughput technologies nowadays, the epigenetic analyses will have possible clinical applications in the molecular pathology of ccRCC. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 1000-9604 1993-0631 |
DOI: | 10.3978/j.issn.1000-9604.2016.02.09 |